SRS Capital Advisors »

Arcutis Biotherapeutics shares owned by SRS Capital Advisors

Quarter-by-quarter ownership of Arcutis Biotherapeutics (ARQT) shares owned by SRS Capital Advisors from 13F filings

Historical chart of SRS Capital Advisors investment in Arcutis Biotherapeutics

Tip: Access up to 7 years of quarterly data

All positions including Arcutis Biotherapeutics held by SRS Capital Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Arcutis Biotherapeutics by SRS Capital Advisors

Quarter filed Position value Share count Share price at filing
2023-12-31 $110 34 3.24
2023-09-30 $255 48 5.31
2023-06-30 $458 48 9.54
2023-03-31 $462 42 11.00
2022-12-31 $502 34 14.79

More positions owned by SRS Capital Advisors

Ishares Tr Ishs 1-5yr Invs (IGSB)
Vanguard Index Fds Value Etf (VTV)
Vanguard Index Fds Growth Etf (VUG)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Schwab Strategic Tr Us Tips Etf (SCHP)
Vanguard Index Fds Mid Cap Etf (VO)
Dimensional Etf Trust Core Fixed Incom (DFCF)
Vanguard Tax-managed Fds Van Ftse Dev Mkt (VEA)
Ishares Tr Iboxx Inv Cp Etf (LQD)
Schwab Strategic Tr Us Lcap Gr Etf (SCHG)
First Tr Exch Traded Fd Iii Pfd Secs Inc Etf (FPE)
Vanguard Index Fds Small Cp Etf (VB)
Ishares Tr S&p 500 Val Etf (IVE)
Ishares Tr Rus 2000 Val Etf (IWN)
Ishares Tr Rus 2000 Grw Etf (IWO)

View all positions for SRS Capital Advisors

Top funds holding Arcutis Biotherapeutics

Jennison Associates
Frazier Life Sciences Management
Vanguard Group
Franklin Resources
Millennium Management
Opaleye Management
Jennifer Ranahan
Deutsche Bank Aktiengesellschaft
Tejara Capital
Two Sigma Investments
Goldman Sachs Group
Charles Schwab Investment Management
Federated Investors
AMI Asset Management Corporation
Walleye Trading Advisors

View all funds holding Arcutis Biotherapeutics